Literature DB >> 9121118

Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system.

T Berger1, S Weerth, K Kojima, C Linington, H Wekerle, H Lassmann.   

Abstract

Recent studies on autoimmune encephalomyelitis and neuritis reveal that many different antigens of the central (CNS) and peripheral nervous system may become targets of an encephalitogenic T-cell response. The aim of this study was to determine the influence of T-cell specificity on the pathology of autoimmune-mediated inflammation in the nervous system. Autoimmune encephalomyelitis was induced by the adoptive transfer of CD4+ T-line cells specific for either myelin basic protein, myelin oligodendrocyte glycoprotein (MOG), myelin-associated glycoprotein, S100 beta, or glial fibrillary acidic protein. The severity of the inflammatory response was antigen- and dose-dependent. With the exception of MOG-specific T-line cells, all autoreactive T-cell lines induced inflammation in the CNS and peripheral nervous system. In the myelin-basic-protein-mediated model, the spinal cord was most severely affected with only minor inflammation in the forebrain. In contrast, both MOG- and myelin-associated-glycoprotein-specific T cells induced a far higher density of lesions in the periventricular and cerebellar white matter. S100 beta- and glial-fibrillary-acidic-protein-specific T cells mediated particularly severe inflammation in the gray matter. In addition to these topographic differences, antigen specificity also influenced the extent of both parenchymal inflammation and macrophage activation in the CNS. However, irrespective of the specificity or number of T cells transferred, the major neuropathologic correlate with disease severity was the absolute number of activated macrophages recruited into the CNS parenchyma (r = 0.9; p < 0.0001). This study suggests that differences in lesion distribution in multiple sclerosis patients may reflect differences in the antigen specificity of an encephalitogenic T-cell response.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9121118

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  39 in total

1.  Disproportionate recruitment of CD8+ T cells into the central nervous system by professional antigen-presenting cells.

Authors:  M J Carson; C R Reilly; J G Sutcliffe; D Lo
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

Review 2.  Immune checkpoints in central nervous system autoimmunity.

Authors:  Nicole Joller; Anneli Peters; Ana C Anderson; Vijay K Kuchroo
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

3.  Transplantation of olfactory ensheathing cells promotes partial recovery in rats with experimental autoimmune encephalomyelitis.

Authors:  Jia Li; Weian Chen; Yu'an Li; Ying Chen; Zhangna Ding; Dehao Yang; Xu Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

4.  MP4- and MOG:35-55-induced EAE in C57BL/6 mice differentially targets brain, spinal cord and cerebellum.

Authors:  Stefanie Kuerten; Dilyana A Kostova-Bales; Lukas P Frenzel; Justine T Tigno; Magdalena Tary-Lehmann; Doychin N Angelov; Paul V Lehmann
Journal:  J Neuroimmunol       Date:  2007-07-25       Impact factor: 3.478

Review 5.  Cortical, subcortical and spinal alterations in neuroimmunological diseases.

Authors:  Hans Lassmann
Journal:  J Neurol       Date:  2007-05       Impact factor: 4.849

6.  The Severity of Spinal Cord Injury Determines the Inflammatory Gene Expression Pattern after Immunization with Neural-Derived Peptides.

Authors:  Elisa García; Raúl Silva-García; Adrian Flores-Romero; Liliana Blancas-Espinoza; Roxana Rodríguez-Barrera; Antonio Ibarra
Journal:  J Mol Neurosci       Date:  2018-05-23       Impact factor: 3.444

7.  T-cell apoptosis in inflammatory brain lesions: destruction of T cells does not depend on antigen recognition.

Authors:  J Bauer; M Bradl; W F Hickley; S Forss-Petter; H Breitschopf; C Linington; H Wekerle; H Lassmann
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

Review 8.  Axo-glial antigens as targets in multiple sclerosis: implications for axonal and grey matter injury.

Authors:  Tobias Derfuss; Chris Linington; Reinhard Hohlfeld; Edgar Meinl
Journal:  J Mol Med (Berl)       Date:  2010-05-06       Impact factor: 4.599

9.  Peripheral third cranial nerve enhancement in multiple sclerosis.

Authors:  M Tariq Bhatti; Ilona M Schmalfuss; Lorna S Williams; Ronald G Quisling
Journal:  AJNR Am J Neuroradiol       Date:  2003-08       Impact factor: 3.825

Review 10.  Lame ducks or fierce creatures? The role of oligodendrocytes in multiple sclerosis.

Authors:  T Zeis; N Schaeren-Wiemers
Journal:  J Mol Neurosci       Date:  2008-02-16       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.